Delcath Systems DCTH Business Segments
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| Product revenue by Product | ||||||
| CHEMOSAT | $1.75M+4.7% | $1.67M+27.4% | $1.31M-20.9% | $1.66M-6.0% | $1.76M+24.7% | |
| HEPZATO KIT | $23.25M+22.0% | $19.06M-1.0% | $19.25M-14.4% | $22.5M+24.8% | $18.02M+31.7% | |
| Number of orphan drug designations granted by FDA by Product | ||||||
| HEPZATO KIT, Doxorubicin | 10.0% | 10.0% | 10.0% | 10.0% | 10.0% | |
| HEPZATO KIT, Melphalan | 50.0% | 50.0% | 50.0% | 50.0% | 50.0% | |
| HEPZATO KIT | 60.0% | 60.0% | 60.0% | 60.0% | 60.0% | |
| Product revenue by Geography | ||||||
| Foreign | $1.75M— | —— | —— | —— | $1.76M+43.7% | |
| U.S. | $23.25M— | —— | —— | —— | $18.02M+123% | |
| Operating Lease, Payments by Geography | ||||||
| Ireland | $11K-54.2% | $24K— | $0-100% | $11K0.0% | $11K-15.4% | |
| U.S. | $36K0.0% | $36K0.0% | $36K0.0% | $36K0.0% | $36K-18.2% | |
| Lessee, Operating Lease, Liability, to be Paid by Geography | ||||||
| Ireland | $15K-44.4% | $27K-30.8% | $39K-23.5% | $51K-12.1% | $58K-10.8% | |
| U.S. | $1.21M-2.9% | $1.25M-2.7% | $1.28M-2.7% | $1.32M-2.7% | $1.35M-2.6% | |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount by Geography | ||||||
| Ireland | $0-100% | $1K0.0% | $1K-50.0% | $2K-33.3% | $3K-25.0% | |
| U.S. | $317K-5.4% | $335K-5.1% | $353K-5.1% | $372K-4.9% | $391K-4.9% | |
| Weighted average discount rate - operating leases by Geography | ||||||
| Ireland | 8%0.0pp | 8%0.0pp | 8%0.0pp | 8%0.0pp | 8%0.0pp | |
| U.S. | 8%0.0pp | 8%0.0pp | 8%0.0pp | 8%0.0pp | 8%0.0pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How does Delcath Systems break its business down?
- Delcath Systems (DCTH) reports product revenue by product across 2 parts — CHEMOSAT and HEPZATO KIT. Each is extracted from the segment footnotes and tracked over time.
- Where does Delcath Systems's segment data come from?
- Segment breakdowns are pulled from the segment footnotes in Delcath Systems's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.
